Matthew Aronson is a Senior Scientist at Merck, specializing in sterile drug product commercialization. Currently a PhD candidate in Bioengineering at the University of Pennsylvania, they focus on host-pathogen interactions during airway fibrosis. Matthew has led significant projects in drug formulation and therapeutic delivery, resulting in 13 publications and 2 patents. With experience in teaching and mentoring, they have presented at 18 conferences, earning multiple awards for their contributions in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices